Selected article for: "Neutralization assay and plaque reduction neutralization"
Author: NISREEN M.A. OKBA; Marcel A Muller; Wentao Li; Chunyan Wang; Corine H. GeurtsvanKessel; Victor M. Corman; Mart M. Lamers; Reina S. Sikkema; Erwin de Bruin; Felicity D. Chandler; Yazdan Yazdanpanah; Quentin Le Hingrat; Diane Descamps; Nadhira Houhou-Fidouh; Chantal B. E. M. Reusken; Berend-Jan Bosch; Christian Drosten; Marion P.G. Koopmans; Bart L. Haagmans
Title: SARS-CoV-2 specific antibody responses in COVID-19 patients
  • Document date: 2020_3_20
    • ID: 9595vm0k_52
    Snippet: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.18.20038059 doi: medRxiv preprint Figure 4 : Sensitivity of the two commercial ELISAs for the detection of SARS-CoV-2 specific IgG (A,C,E) and IgA (B,D,F) antibodies. Kinetics of antibody responses in 9 COVID-19 patients from Germany (A,B). Correlation between antibody responses detected by the ELISAs and the plaque reduction neutralizati.....
    Document: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.18.20038059 doi: medRxiv preprint Figure 4 : Sensitivity of the two commercial ELISAs for the detection of SARS-CoV-2 specific IgG (A,C,E) and IgA (B,D,F) antibodies. Kinetics of antibody responses in 9 COVID-19 patients from Germany (A,B). Correlation between antibody responses detected by the ELISAs and the plaque reduction neutralization assay (PRNT50; C,D). (E,F) The kits were tested for specificity using18 serum samples from HCoV (4x HCoV-229E, 3x HCoV-HKU1, 4x HCoV-NL63, 7x HCoV-OC43) as well as MERS-CoV (n=3) and SARS-CoV (n=3) infected persons.

    Search related documents:
    Co phrase search for related documents
    • antibody response and commercial elisa sensitivity: 1
    • antibody response and neutralization assay: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antibody response and plaque reduction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • antibody response and plaque reduction elisa: 1, 2
    • antibody response and serum sample: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • antibody response and specificity test: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • commercial elisa and neutralization assay: 1, 2, 3, 4, 5, 6, 7
    • commercial elisa and plaque reduction: 1, 2
    • commercial elisa and serum sample: 1
    • commercial elisa and specificity test: 1, 2, 3, 4, 5
    • commercial elisa sensitivity and neutralization assay: 1
    • commercial elisa sensitivity and specificity test: 1, 2, 3
    • kit specificity test and specificity test: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • neutralization assay and plaque reduction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • neutralization assay and plaque reduction elisa: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • neutralization assay and serum sample: 1, 2, 3
    • neutralization assay and specificity test: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • plaque reduction and serum sample: 1, 2, 3
    • plaque reduction and specificity test: 1, 2, 3